Literature DB >> 27856528

In Vivo Hepatic Enhancer Elements in the Human ABCG2 Locus.

Rachel J Eclov1, Mee J Kim1, Robin P Smith1, Xiaomin Liang1, Nadav Ahituv1, Deanna L Kroetz2.   

Abstract

ABCG2 encodes the mitoxantrone resistance protein (MXR; breast cancer resistance protein), an ATP-binding cassette (ABC) efflux membrane transporter. Computational analysis of the ∼300 kb region of DNA surrounding ABCG2 (chr4:88911376-89220011, hg19) identified 30 regions with potential cis-regulatory capabilities. These putative regulatory regions were tested for their enhancer and suppressor activity in a human liver cell line using luciferase reporter assays. The in vitro enhancer and suppressor assays identified four regions that decreased gene expression and five regions that increased expression >1.6-fold. Four of five human hepatic in vitro enhancers were confirmed as in vivo liver enhancers using the mouse hydrodynamic tail vein injection assay. Two of the in vivo liver enhancers (ABCG2RE1 and ABCG2RE9) responded to 17β-estradiol or rifampin in human cell lines, and ABCG2RE9 had ChIP-seq evidence to support the binding of several transcription factors and the transcriptional coactivator p300 in human hepatocytes. This study identified genomic regions surrounding human ABCG2 that can function as regulatory elements, some with the capacity to alter gene expression upon environmental stimulus. The results from this research will drive future investigations of interindividual variation in ABCG2 expression and function that contribute to differences in drug response.
Copyright © 2017 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27856528      PMCID: PMC5267518          DOI: 10.1124/dmd.116.072033

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  53 in total

1.  ECR Browser: a tool for visualizing and accessing data from comparisons of multiple vertebrate genomes.

Authors:  Ivan Ovcharenko; Marcelo A Nobrega; Gabriela G Loots; Lisa Stubbs
Journal:  Nucleic Acids Res       Date:  2004-07-01       Impact factor: 16.971

2.  Differential regulation of sinusoidal and canalicular hepatic drug transporter expression by xenobiotics activating drug-sensing receptors in primary human hepatocytes.

Authors:  Emilie Jigorel; Marc Le Vee; Claire Boursier-Neyret; Yannick Parmentier; Olivier Fardel
Journal:  Drug Metab Dispos       Date:  2006-07-12       Impact factor: 3.922

3.  Expression of breast cancer resistance protein in blast cells from patients with acute leukemia.

Authors:  D D Ross; J E Karp; T T Chen; L A Doyle
Journal:  Blood       Date:  2000-07-01       Impact factor: 22.113

4.  Estrogen receptor, a common interaction partner for a subset of nuclear receptors.

Authors:  S K Lee; H S Choi; M R Song; M O Lee; J W Lee
Journal:  Mol Endocrinol       Date:  1998-08

5.  Progesterone receptor (PR) isoforms PRA and PRB differentially regulate expression of the breast cancer resistance protein in human placental choriocarcinoma BeWo cells.

Authors:  Honggang Wang; Eun-Woo Lee; Lin Zhou; Peter C K Leung; Douglas D Ross; Jashvant D Unadkat; Qingcheng Mao
Journal:  Mol Pharmacol       Date:  2007-11-27       Impact factor: 4.436

6.  Association of breast cancer resistance protein/ABCG2 phenotypes and novel promoter and intron 1 single nucleotide polymorphisms.

Authors:  Balasubramanian Poonkuzhali; Jatinder Lamba; Stephen Strom; Alex Sparreboom; Kenneth Thummel; Paul Watkins; Erin Schuetz
Journal:  Drug Metab Dispos       Date:  2008-01-07       Impact factor: 3.922

7.  A user's guide to the encyclopedia of DNA elements (ENCODE).

Authors: 
Journal:  PLoS Biol       Date:  2011-04-19       Impact factor: 8.029

8.  A high resolution genome-wide scan of HNF4α recognition sites infers a regulatory gene network in colon cancer.

Authors:  Fridtjof Weltmeier; Juergen Borlak
Journal:  PLoS One       Date:  2011-07-28       Impact factor: 3.240

9.  Coding exons function as tissue-specific enhancers of nearby genes.

Authors:  Ramon Y Birnbaum; E Josephine Clowney; Orly Agamy; Mee J Kim; Jingjing Zhao; Takayuki Yamanaka; Zachary Pappalardo; Shoa L Clarke; Aaron M Wenger; Loan Nguyen; Fiorella Gurrieri; David B Everman; Charles E Schwartz; Ohad S Birk; Gill Bejerano; Stavros Lomvardas; Nadav Ahituv
Journal:  Genome Res       Date:  2012-03-22       Impact factor: 9.043

10.  Impact of cellular folate status and epidermal growth factor receptor expression on BCRP/ABCG2-mediated resistance to gefitinib and erlotinib.

Authors:  C Lemos; I Kathmann; E Giovannetti; C Calhau; G Jansen; G J Peters
Journal:  Br J Cancer       Date:  2009-03-10       Impact factor: 7.640

View more
  2 in total

1.  Rare Variants in the ABCG2 Promoter Modulate In Vivo Activity.

Authors:  Rachel J Eclov; Mee J Kim; Robin Smith; Nadav Ahituv; Deanna L Kroetz
Journal:  Drug Metab Dispos       Date:  2018-02-21       Impact factor: 3.922

2.  ABCG2 regulatory single-nucleotide polymorphisms alter in vivo enhancer activity and expression.

Authors:  Rachel J Eclov; Mee J Kim; Aparna Chhibber; Robin P Smith; Nadav Ahituv; Deanna L Kroetz
Journal:  Pharmacogenet Genomics       Date:  2017-12       Impact factor: 2.089

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.